Novartis AG
Compounds and compositions as toll-like receptor 7 agonists
Last updated:
Abstract:
The invention provides compounds of Formula (I), immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat diseases or disorders associated with Toll-Like Receptor 7 activity. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
24 Jul 2019
Issue date:
24 Nov 2020